Archives

The VALIDATE Network aims to accelerate vaccine development for globally significant diseases caused by complex neglected intracellular pathogens. Our initial focus is on TB, leishmaniasis, [...]

Archivel Farma S.L. has a vacancy for a Postdoctoral Researcher to join the R&D department through a Torres Quevedo call, February 2019. For more information, please read the vacancy text.

The University of Geneva has opened a tenure-track position for an assistant professor of human vaccine immunology… endowed by a Charity prior to a permanent University position as [...]

Prof. Kaufmann, chair of the scientific board of TBVAC2020 and member of the TBVI board, was honored with the Gagna A. & Ch. Van Heck Prize in recognition of his and his team’s work on [...]

On 6-7 June the kick off meeting of MTBVAC in Newborns took place in Cape Town, South Africa. This project contains a Phase 2a dose-defining safety and immunogenicity study is being carried out. [...]

EDCTP commits EUR 34M to TB vaccine clinical trials. True to the World Tuberculosis Day 2018 theme ‘Wanted: Leaders for a TB-free world’, the European Union and European member states continue to [...]

The initial results of the Phase 1b study have been presented at the 5th Global Forum on TB vaccines in Delhi. Please read the press release.

A new TB vaccine is an inevitability; the question is how long will it take us to get there? Please read the article about progress and challenges in TB vaccine development.

The Global Report on Tuberculosis Vaccines 2018 is prepared at the request of the Global TB Vaccine Partnership (GTBVP) leadership group. The report will be completed following the 5th Global [...]

From 29 January – 1 February 2018 the TBVI symposium and TBVAC2020 annual meeting took place in Les Diablerets, Switzerland. This yearly event was attended by over 140 participants from 70 [...]